Skip to main content
Cameron Herr, DO, Endocrinology, Parkville, MO

Cameron Cody Lynn Herr DO MBA

Endocrinology•Parkville, MO

Diabetes, Lipid Metabolism, Obesity, Thyroid

Endocrinologist

Join to View Full Profile

  • 6185 NW Jefferson StParkville, MO 64152

  • Phone+1 816-880-2600

  • Fax+1 816-880-2640

Dr. Herr is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Herr's Full ProfileAlready have an account?

Education & Training

  • University of Missouri-Columbia
    University of Missouri-ColumbiaFellowship, Endocrinology, Diabetes, and Metabolism, 2015 - 2017
  • University of Missouri-Columbia
    University of Missouri-ColumbiaResidency, Internal Medicine, 2012 - 2015
  • Rockhurst University Helzberg School of Mgmt
    Rockhurst University Helzberg School of MgmtMBA, 2012 - 2015
  • Rockhurst University
    Rockhurst UniversityMBA, Healthcare, 2012
  • Kansas City University of Medicine and Biosciences College of Osteopathic Medicine
    Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2012

Certifications & Licensure

  • MO State Medical License
    MO State License 2015 - 2027

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2016
  • CMS Meaningful Use Stage 1 Certification FirstNet (Clinical), Cerner Corporation, 2016
  • CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2016

Publications & Presentations

Abstracts/Posters

  • Rare Family Study of Albright's Hereditary Osteodystrophy (Pseudohypoparathyroidism) in Multiple Male Members.
    Cabandugama, P., Herr, C., Harbuz-Miller, I., Gardner, M., Klachko, D, AACE Poster, University of Missouri at Columbia, Division of Endocrinology, 1/1/2017

Press Mentions

  • The Other Epidemic: Branford Woman Seeks to Raise Awareness of Fentanyl After Death of Nephew
    The Other Epidemic: Branford Woman Seeks to Raise Awareness of Fentanyl After Death of NephewSeptember 7th, 2021
  • New Haven Celebrates International Overdose Awareness Day
    New Haven Celebrates International Overdose Awareness DayAugust 31st, 2021

Research History

  • Co-InvestigatorBayer - FIDELIO and FIGARO. Sub-Investigator. Randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven, phase III study to investigate efficacy and safety of finerenone on reduction of cardiovascular morbidity and mortality.2015 - 2017

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Cameron Herr, Dr. Cameron Herr, DO, Dr. C Herr, Dr. Cameron Cody Lynn Herr